The Breast
Volume 19, Issue 1 , Pages 14-22 , February 2010

Are mastectomy resection margins of clinical relevance? A systematic review

  • N.P. Rowell

      Affiliations

    • Corresponding Author InformationTel: +44 1622 225103; fax: +44 1622 225074.

Received 11 June 2009 ,Revised 9 September 2009 ,Accepted 17 October 2009.

References 

  1. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–2106
  2. Rowell NP. Radiotherapy to the chest wall following mastectomy for node-negative breast cancer: a systematic review. Radiother Oncol. 2009;91:23–32
  3. Association of Breast Surgery at BASO , Royal College of Surgeons of England . Guidelines for the management of symptomatic breast disease. Eur J Surg Oncol. 2005;31:S1–S21
  4. Scottish Intercollegiate Guidelines Network . Management of breast cancer in women. A national clinical guideline. Available at: http://www.sign.ac.uk/guidelines/published/index.html2005;
  5. Recht A, Edge SB, Solin LJ, Robinson DS, Estabrook A, Fine RE, et al. Postmastectomy radiotherapy: guidelines of the American Society of Clinical Oncology. J Clin Oncol. 2001;19:1539–1569
  6. NCCN . Practice guidelines in oncology: invasive breast cancer. Version 1 National Comprehensive Cancer Network; 2009;Available at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp
  7. Truong PT, Olivotto IA, Whelan TJ, Levine M. Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy. Can Med Assoc J. 2004;170:1263–1273
  8. Pierce LJ. The use of radiotherapy after mastectomy: a review of the literature. J Clin Oncol. 2005;23:1706–1717
  9. Sozzi WJ, Mirimanoff RO. Indications de la radiotherapie dans le cancer du sein non metastatique. Revue Medicale Suisse. 2007;130:2398–2404
  10. Mentzer SJ, Osteen RT, Wilson RE. Local recurrence and the deep resection margin in carcinoma of the breast. Surg Gynecol Obst. 1986;163:513–517
  11. Ahlborn TN, Gump FE, Bodian C, Habif DV, Kister S. Tumour to fascia margin as a factor in local recurrence after modified radical mastectomy. Surg Gynecol Obst. 1988;166:523–526
  12. Imperato PJ, Waisman J, Wallen MD, Llewellyn CC, Pryor V. Improvements in breast cancer pathology practices among medicare patients undergoing unilateral extended simple mastectomy. Am J Med Quality. 2003;18:164–170
  13. Van Houtte P, Bourgois N, Renard F, Huget P, D'hoore W, Scalliet P. A federal audit of the Belgian radiotherapy departments in breast cancer treatment. Radiother Oncol. 2007;83:178–186
  14. Fowble B, Gray R, Gilchrist K, Goodman RL, Taylor S, Tormey DC. Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. J Clin Oncol. 1988;6:1107–1117
  15. Huang EH, Tucker SL, Strom EA, McNeese MD, Kuerer HM, Hortobagyi GN, et al. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy. Int J Radiat Oncol Biol Phys. 2005;62:351–357
  16. Katz A, Strom EA, Buchholz TA, Theriault R, Singletary SE, McNeese MD. The influence of pathologic tumour characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys. 2001;50:735–742
  17. Nielsen HM, Overgaard M, Grau C, Jensen AR, Overgaard J. Loco-regional recurrence after mastectomy in high-risk breast cancer – risk and prognosis. An analysis of patients from the DBCG 82 b&c randomisation trials. Radiother Oncol. 2006;79:147–155
  18. Woodward WA, Strom EA, Tucker SL, Katz A, McNeese MD, Perkins GH, et al. Locoregional recurrence after doxorubicin-based chemotherapy: implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation. Int J Radiat Oncol Biol Phys. 2003;57:336–344
  19. Coulombe G, Tyldesley S, Speers C, Paltiel C, Aquino-Parsons C, Bernstein V, et al. Is mastectomy superior to breast-conserving treatment for young women?. Int J Radiat Oncol Biol Phys. 2007;67:1282–1290
  20. Truong PT, Olivotto IA, Speers CH, Wai ES, Berthelet E, Kader HA. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer. Int J Radiat Oncol Biol Phys. 2004;58:797–804
  21. Truong PT, Olivotto IA, Kader HA, Panades M, Speers CH, Berthelet E. Selecting breast cancer patients with T1–T2 tumours and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys. 2005;61:1337–1347
  22. Macdonald G, Paltiel C, Olivotto IA, Tyldesley S. A comparative analysis of radiotherapy use and patient outcome in males and females with breast cancer. Ann Oncol. 2005;16:1442–1448
  23. Review Manager [Computer program]. Version 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2008;
  24. Bristol IJ, Woodward WA, Strom EA, Cristofanilli M, Domain D, Singletary SE, et al. Locoregional treatment outcomes after multimodality management of inflammatory breast cancer. Int J Radiat Oncol Biol Phys. 2008;72:474–484
  25. Curcio LD, Rupp E, Williams WL, Chu DZJ, Clarke K, Odom-Maryon T, et al. Beyond palliative mastectomy in inflammatory breast cancer – a reassessment of margin status. Ann Surg Oncol. 1999;6:249–254
  26. Hehr T, Classen J, Huth M, Durst I, Christ G, Bamberg M, et al. Postmastectomy radiotherapy of the chest wall. Comparison of electron-rotation technique and common tangential photon fields. Strahlenther Onkol. 2004;180:629–636
  27. Jagsi R, Raad RA, Goldberg S, Sullivan T, Michaelson J, Powell SN, et al. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation. Int J Radiat Oncol Biol Phys. 2005;62:1035–1039
  28. Alassas M, Chu Q, Burton G, Ampil F, Mizell J, Li BD. Neoadjuvant chemotherapy in stage III breast cancer. Am Surg. 2005;71:487–492
  29. Atahan IL, Ozyigit G, Yildiz F, Gurkaynak M, Selek U, Sari S, et al. Percent positive axillary involvement predicts for the development of brain metastasis in high-risk patients with nonmetastatic breast cancer receiving post-mastectomy radiotherapy. Breast Journal. 2008;14:245–249
  30. Cheng SH, Horng CF, Clarke JL, Tsou MH, Tsai SY, Chen CM, et al. Prognostic index score and clinical prediction model of local regional recurrence after mastectomy in breast cancer patients. Int J Radiat Oncol Biol Phys. 2006;64:1401–1409
  31. Feigenberg SJ, Mendenhall NP, Benda RK, Morris CG. Postmastectomy radiotherapy: patterns of recurrence and long-term disease control using electrons. Int J Radiat Oncol Biol Phys. 2003;56:716–725
  32. Freedman GM, Fowble BL, Hanlon AL, Myint MA, Hoffman JP, Sigurdson ER, et al. A close or positive margin after mastectomy is not an indication for chest wall irradiation except in women aged fifty or younger. Int J Radiat Oncol Biol Phys. 1998;41:599–605
  33. Horiguchi J, Koibuchi Y, Yoshida T, Takata D, Kikuchi M, Rokutanda N, et al. Significance of local recurrence as a prognostic factor in the treatment of breast cancer. Anticancer Res. 2006;26:569–574
  34. Jager JJ, Volovics L, Schouten LJ, de Jong JMA, Hupperets PSGJ, von Meyenfeldt MF, et al. Loco-regional recurrences after mastectomy in breast cancer: prognostic factors and implications for postoperative irradiation. Radiother Oncol. 1999;50:267–275
  35. Lagios MD, Richards VE, Rose MR, Yee E. Segmental mastectomy without radiotherapy: short-term follow-up. Cancer. 1983;52:2173–2179
  36. Livi L, Saieva C, Detti B, Meattini I, Susini T, Paiar F, et al. Loco-regional recurrence in 2064 patients with breast cancer treated with mastectomy without adjuvant radiotherapy. Eur J Surg Oncol. 2007;33:977–981
  37. Miccoli P, Iacconi P, Spinelli C, Di Candio G. Opération de Halsted versus mastectomie radicale modifiée: utilité d'une sélection des patients en fonction du type et de la localisation de la tumeur. Acta Chir Belg. 1984;84:39–41
  38. Punglia RS, Hughes ME, Edge SB, Theriault RL, Brookman MA, Wilson JL, et al. Factors associated with guideline-concordant use of radiotherapy after mastectomy in the National Comprehensive Cancer Network. Int J Radiat Oncol Biol Phys. 2008;72:1434–1440
  39. Chin PL, Andersen JS, Somlo G, Chu DZ, Schwarz RE, Ellenhorn JD. Esthetic reconstruction after mastectomy for inflammatory breast cancer: is it worthwhile?. J Am Coll Surg. 2000;190:304–309
  40. Downes KJ, Glatt BS, Kanchwala SK, Mick R, Fraker DL, Fox KR, et al. Skin-sparing mastectomy and immediate reconstruction is an acceptable treatment option for patients with high-risk breast carcinoma. Cancer. 2005;103:906–913
  41. Vaughan A, Dietz JR, Aft R, Gillanders WE, Eberlein TJ, Freer P, et al. Patterns of local breast cancer recurrence after skin-sparing mastectomy and immediate breast reconstruction. Am J Surg. 2007;194:438–443

PII: S0960-9776(09)00136-2

doi: 10.1016/j.breast.2009.10.007

The Breast
Volume 19, Issue 1 , Pages 14-22 , February 2010

Article Tools

* Image Usage & Resolution